News & AnalysisBabson Diagnostics inks $31m Series BBabson Diagnostics, a medical technology company, has raised $31 million in Series B funding.ByIris Dorbian1 July 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs